The MDSC and T-regulatory cell populations eventually begin to repopulate the tumor area while CD8+ and double-positive T cell populations decline by Day 14 post-treatment, which also coincides with the contralateral tumor reduction and regrowth timelines. The gene discussed is CD8A; the disease is neoplasm.